focus -WSS

focus

author：comprehensive 2025-09-05 09:11:32 - browse：56

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： FDA approves Moderna’s RSV vaccine, its second licensed product

WSS

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

How CO2 helps viruses stay alive longer in the air

When is a doctor not a doctor? Try when patients address women doctors

Community addresses injustice for Long Island mothers

For pregnant people, addiction treatment shouldn't mean a call to child protective services

focus

focus

focus

In Memoriam: Notable people who died in 2023

CMS got Medicare Advantage quality rating wrong, judge rules

ChatGPT in medicine: STAT answers readers' burning questions

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Medicare details structure of new drug price negotiation program

These geoengineering technologies could help combat the climate crisis, scientists say

Hepatitis C has a cure — but many Americans still lack access to it

Stopping antidepressants leads to symptoms for 1 in 6 patients

In age of alternative facts, a scholarly course on calling out crap

FDA approves Moderna’s RSV vaccine, its second licensed product

focus

7 people shot in DC, police say

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Inside the fall of star MIT scientist David Sabatini

Stopping antidepressants leads to symptoms for 1 in 6 patients

An outdated Medicare rule harms dementia patients with anxiety

Doctor appointment wait times are getting worse

Wikipedia

leisure time

hotspot

entertainment